{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:08:23Z","timestamp":1779448103958,"version":"3.53.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00415-026-13797-y","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T17:25:03Z","timestamp":1776533103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Corneal edema: an underrecognized safety risk of amantadine"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5561-6940","authenticated-orcid":false,"given":"David","family":"Croteau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tobenkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Branagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Goldrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Freilich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Brinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"13797_CR1","unstructured":"Symmetrel (amantadine hydrochloride) Prescribing Information. Endo Pharmaceuticals Inc. Chadds Ford, PA. January 2009. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/016023s041,018101s016lbl.pdf. Accessed 9 March 2026."},{"key":"13797_CR2","unstructured":"Gocovri (amantadine) Prescribing Information. Adamas Pharma, LLC. Emeryville, CA. August 2017. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/208944s009lbl.pdf. Accessed 9 March 2026."},{"issue":"12","key":"13797_CR3","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1474-4422(21)00249-0","volume":"20","author":"O Rascol","year":"2021","unstructured":"Rascol O, Fabbri M, Poewe W (2021) Amantadine in the treatment of Parkinson\u2019s disease and other movement disorders. Lancet Neurol 20(12):1048\u20131056. https:\/\/doi.org\/10.1016\/S1474-4422(21)00249-0","journal-title":"Lancet Neurol"},{"issue":"34","key":"13797_CR4","doi-asserted-by":"publisher","first-page":"57316","DOI":"10.18632\/oncotarget.17622","volume":"8","author":"M Kong","year":"2017","unstructured":"Kong M, Ba M, Ren C et al (2017) An updated meta-analysis of amantadine for treating dyskinesia in Parkinson\u2019s disease. Oncotarget 8(34):57316\u201357326. https:\/\/doi.org\/10.18632\/oncotarget.17622","journal-title":"Oncotarget"},{"issue":"5","key":"13797_CR5","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/mds.30162","volume":"40","author":"RMA de Bie","year":"2025","unstructured":"de Bie RMA, Katzenschlager R, Swinnen BEKS et al (2025) Update on treatments for Parkinson\u2019s disease motor fluctuations: an international Parkinson and movement disorder society evidence-based medicine review. Mov Disord 40(5):776\u2013794. https:\/\/doi.org\/10.1002\/mds.30162","journal-title":"Mov Disord"},{"issue":"8","key":"13797_CR6","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/mds.27372","volume":"33","author":"SH Fox","year":"2018","unstructured":"Fox SH, Katzenschlager R, Lim SY et al (2018) International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson\u2019s disease. Mov Disord 33(8):1248\u20131266. https:\/\/doi.org\/10.1002\/mds.27372","journal-title":"Mov Disord"},{"key":"13797_CR7","unstructured":"Ludwig PE, Lopez MJ, Sevensma KE. Anatomy, Head and Neck, Eye Cornea. 2023 Aug 7 :In StatPearls. Treasure Island (FL): StatPearls Publishing; 2025 Jan\u2013. PMID: 29262108."},{"issue":"3","key":"13797_CR8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jcrs.2010.12.037","volume":"37","author":"DW DelMonte","year":"2011","unstructured":"DelMonte DW, Kim T (2011) Anatomy and physiology of the cornea. J Cataract Refract Surg 37(3):588\u2013598. https:\/\/doi.org\/10.1016\/j.jcrs.2010.12.037","journal-title":"J Cataract Refract Surg"},{"issue":"6","key":"13797_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/cxo.12060","volume":"96","author":"C Costagliola","year":"2013","unstructured":"Costagliola C, Romano V, Forbice E, Angi M, Pascotto A, Boccia T, Semeraro F (2013) Corneal oedema and its medical treatment. Clin Exp Optom 96(6):529\u2013535. https:\/\/doi.org\/10.1111\/cxo.12060","journal-title":"Clin Exp Optom"},{"key":"13797_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/2515841418815802","volume":"10","author":"S Feizi","year":"2018","unstructured":"Feizi S (2018) Corneal endothelial cell dysfunction: etiologies and management. Ther Adv Ophthalmol 10:2515841418815802. https:\/\/doi.org\/10.1177\/2515841418815802","journal-title":"Ther Adv Ophthalmol"},{"issue":"3","key":"13797_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jaapos.2022.01.005","volume":"26","author":"J Chao","year":"2022","unstructured":"Chao J, Dunn S, Bohra L (2022) Amantadine-induced bilateral corneal edema in a pediatric patient. J AAPOS 26(3):150\u2013152. https:\/\/doi.org\/10.1016\/j.jaapos.2022.01.005","journal-title":"J AAPOS"},{"key":"13797_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2023.101881","volume":"32","author":"A Raharaja","year":"2023","unstructured":"Raharaja A, Mina W, Ashena Z (2023) Amantadine-induced corneal edema: a case and literature review. Am J Ophthalmol Case Rep 32:101881. https:\/\/doi.org\/10.1016\/j.ajoc.2023.101881","journal-title":"Am J Ophthalmol Case Rep"},{"key":"13797_CR13","unstructured":"Questions and Answers on FDA\u2019s Adverse Event Reporting System (FAERS). https:\/\/www.fda.gov\/drugs\/surveillance\/fdas-adverse-event-reporting-system-faers. Accessed 9 March 2026."},{"issue":"3","key":"13797_CR14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/cpt.3701","volume":"118","author":"E Potter","year":"2025","unstructured":"Potter E, Reyes M, Naples J, Dal Pan G (2025) FDA adverse event reporting system (FAERS) essentials: a guide to understanding, applying, and interpreting adverse event data reported to FAERS. Clin Pharmacol Ther 118(3):567\u2013582. https:\/\/doi.org\/10.1002\/cpt.3701","journal-title":"Clin Pharmacol Ther"},{"key":"13797_CR15","unstructured":"Best Practices in Drug and Biological Product Postmarket Safety Surveillance for FDA Staff. November 2019. https:\/\/www.fda.gov\/media\/130216\/download?attachment. Accessed 9 March 2026."},{"issue":"18","key":"13797_CR16","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT et al (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789\u20131799. https:\/\/doi.org\/10.1212\/01.WNL.0000287431.88658.8b","journal-title":"Neurology"},{"issue":"1","key":"13797_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1001\/jamaophthalmol.2017.4655","volume":"136","author":"T Chan","year":"2018","unstructured":"Chan T, Friedman DS, Bradley C, Massof R (2018) Estimates of incidence and prevalence of visual impairment, low vision, and blindness in the United States. JAMA Ophthalmol 136(1):12\u201319. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.4655","journal-title":"JAMA Ophthalmol"},{"key":"13797_CR18","unstructured":"CFR 314.80 eCFR :: 21 CFR 314.80 -- Postmarketing reporting of adverse drug experiences. Accessed 9 March 2026"},{"issue":"5","key":"13797_CR19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1056\/NEJMra2401857","volume":"391","author":"CM Tanner","year":"2024","unstructured":"Tanner CM, Ostrem JL (2024) Parkinson\u2019s disease. N Engl J Med 391(5):442\u2013452. https:\/\/doi.org\/10.1056\/NEJMra2401857","journal-title":"N Engl J Med"},{"issue":"8","key":"13797_CR20","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1097\/ICO.0000000000001941","volume":"38","author":"N Mancera","year":"2019","unstructured":"Mancera N, Wadia HP (2019) Corneal edema associated with systemic dopaminergic agents. Cornea 38(8):1040\u20131042. https:\/\/doi.org\/10.1097\/ICO.0000000000001941","journal-title":"Cornea"},{"issue":"10","key":"13797_CR21","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jamaophthalmol.2015.2180","volume":"133","author":"RJ Symes","year":"2015","unstructured":"Symes RJ, Etminan M, Mikelberg FS (2015) Risk of angle-closure glaucoma with bupropion and topiramate. JAMA Ophthalmol 133(10):1187\u20131189. https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.2180","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"13797_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.tjo.2014.04.003","volume":"4","author":"CC Lin","year":"2014","unstructured":"Lin CC, Chieh YC, Hu PS et al (2014) Amantadine-related corneal edema and endothelial cell loss: Four case reports. Taiwan J of Ophthalmology. 4(3):137\u2013140. https:\/\/doi.org\/10.1016\/j.tjo.2014.04.003","journal-title":"Taiwan J of Ophthalmology."},{"issue":"9","key":"13797_CR23","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/mds.27454","volume":"33","author":"L Guo","year":"2018","unstructured":"Guo L, Normando E, Shah P et al (2018) Oculo-visual abnormalities in Parkinson\u2019s disease: possible value as biomarkers. Mov Disord 33(9):1390\u20131406. https:\/\/doi.org\/10.1002\/mds.27454","journal-title":"Mov Disord"},{"key":"13797_CR24","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1093\/brain\/aww175","volume":"139","author":"R Weil","year":"2016","unstructured":"Weil R, Schrag A, Warren J et al (2016) Visual dysfunction in Parkinson\u2019s disease. Brain 139:2827\u20132843. https:\/\/doi.org\/10.1093\/brain\/aww175","journal-title":"Brain"},{"issue":"6","key":"13797_CR25","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.ophtha.2009.10.039","volume":"117","author":"CC Chang","year":"2010","unstructured":"Chang CC, Jeong JH, Kim MK et al (2010) The effect of amantadine on corneal endothelium in subjects with Parkinson\u2019s disease. Ophthalmology 117(6):1214\u20131219. https:\/\/doi.org\/10.1016\/j.ophtha.2009.10.039","journal-title":"Ophthalmology"},{"key":"13797_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.exer.2019.02.010","volume":"181","author":"CE Dudley","year":"2019","unstructured":"Dudley CE, Morell AJ, Duffey ME et al (2019) Effects of amantadine on corneal endothelium. Exp Eye Res 181:208\u2013212. https:\/\/doi.org\/10.1016\/j.exer.2019.02.010","journal-title":"Exp Eye Res"},{"issue":"C","key":"13797_CR27","doi-asserted-by":"publisher","first-page":"C40","DOI":"10.1016\/s0149-2918(98)80007-6","volume":"20","author":"SA Goldman","year":"1998","unstructured":"Goldman SA (1998) Limitations and strengths of spontaneous reports data. Clin Ther 20(C):C40\u2013C44. https:\/\/doi.org\/10.1016\/s0149-2918(98)80007-6","journal-title":"Clin Ther"},{"issue":"13","key":"13797_CR28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.13.1588","volume":"288","author":"B Begaud","year":"2002","unstructured":"Begaud B, Martin K, Haramburu F, Moore N (2002) Rates of spontaneous reporting of adverse drug reactions in France. JAMA 288(13):1588. https:\/\/doi.org\/10.1001\/jama.288.13.1588","journal-title":"JAMA"},{"issue":"24","key":"13797_CR29","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1001\/jama.286.24.3081","volume":"286","author":"L La Grenade","year":"2001","unstructured":"La Grenade L, Graham DJ, Nourjah P (2001) Underreporting of hemorrhagic stroke associated with phenylpropanolamine. JAMA 286(24):3081. https:\/\/doi.org\/10.1001\/jama.286.24.3081","journal-title":"JAMA"},{"key":"13797_CR30","unstructured":"Guidance for Industry Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment. March 2005. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/good-pharmacovigilance-practices-and-pharmacoepidemiologic-assessment. Accessed 9 March 2026."}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13797-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13797-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13797-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:44:34Z","timestamp":1779446674000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13797-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["13797"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13797-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D. Croteau reports no disclosures (financial, non-financial, direct, or indirect) relevant to the manuscript. A. Tobenkin reports no disclosures (financial, non-financial, direct, or indirect) relevant to the manuscript. V. Chan reports no disclosures (financial, non-financial, direct, or indirect) relevant to the manuscrip.t N. Branagan reports no disclosures (financial, non-financial, direct, or indirect) relevant to the manuscript. J. Goldrich reports no disclosures (financial, non-financial, direct, or indirect) relevant to the manuscript. E. Freilich reports no disclosures (financial, non-financial, direct, or indirect) relevant to the manuscript A. Brinker reports no disclosures (financial, non-financial, direct, or indirect) relevant to the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of publication"}}],"article-number":"279"}}